Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Uniphar PLC ( (GB:UPR) ).
Uniphar plc has disclosed share transactions by Chief Executive Officer Gerard Rabbette and Chief Financial Officer Timothy Dolphin involving the company’s Executive Restricted Share Plan. On 9 April, an employee benefit trust purchased Uniphar ordinary shares on their behalf while both executives sold shares that were released from the 2021 plan, with all trades executed at €3.8629 on Euronext Dublin.
Following these transactions, Rabbette retains an interest in 7,334,772 Uniphar shares and Dolphin in 5,610,856 shares, signalling that both senior executives continue to hold substantial equity stakes in the company. The activity reflects routine administration of Uniphar’s long-term incentive arrangements and provides investors with transparency on insider dealings in line with EU market abuse regulations.
More about Uniphar PLC
Uniphar plc is a healthcare services group headquartered in Ireland, with its shares listed on Euronext Dublin. The company is involved in distributing pharmaceutical and medical products and providing related commercial and clinical services to manufacturers, healthcare providers, and patients across various European markets.
See more insights into UPR stock on TipRanks’ Stock Analysis page.